Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery S. Farzi, T. Stojakovic, Th. Marko, C. Sankin, P. Rehak, R. Gumpert, A. Baumann, B. Höfler, H. Metzler, E. Mahla British Journal of Anaesthesia Volume 110, Issue 4, Pages 554-560 (April 2013) DOI: 10.1093/bja/aes454 Copyright © 2013 The Author(s) Terms and Conditions
Fig 1 ROC curve of preoperative NT-proBNP to predict the composite endpoint of non-fatal MI, acute heart failure, and all-cause mortality between index surgery and 3 yr follow-up. The blue line represents the non-discrimination curve. The AUC is 0.77 (95% CI: 0.71–0.82). British Journal of Anaesthesia 2013 110, 554-560DOI: (10.1093/bja/aes454) Copyright © 2013 The Author(s) Terms and Conditions
Fig 2 ROC curve of postoperative NT-proBNP to predict the composite endpoint of non-fatal MI, acute heart failure, and all-cause mortality between index surgery and 3 yr follow-up. The blue line represents the non-discrimination curve. The AUC is 0.73 (95% CI: 0.66–0.78). British Journal of Anaesthesia 2013 110, 554-560DOI: (10.1093/bja/aes454) Copyright © 2013 The Author(s) Terms and Conditions
Fig 3 Kaplan–Meier event–time curve according to preoperative NT-proBNP level. British Journal of Anaesthesia 2013 110, 554-560DOI: (10.1093/bja/aes454) Copyright © 2013 The Author(s) Terms and Conditions